 phase chronic daily dosing oral etoposide combination cisplatin patients advanced cancer dose escalation study daily oral etoposide cisplatin patients advanced cancer doses etoposide days cisplatin IV day total courses Myelosuppression major dose-limiting toxicity maximum tolerated dose oral etoposide days IV cisplatin day Doses etoposide days cisplatin day courses Grade leukopenia days Grade thrombocytopenia dose level Nausea vomiting patients dose level mild antiemetics Alopecia Significant mucositis Grade patient toxicities partial responses months patients cervical patient small cell lung patient squamous cell lung cancer patients platin analogue-containing regimens recommended doses Phase II studies schedule oral etoposide days IV cisplatin day combination regimen schedule effective patients etoposide-sensitive malignancies